Skip To Main Content
Akshay Desai on Muck Rack

Akshay Desai

As seen in: Medium, JAMA (The Journal of the American Medical Association), JAMA: Journal of the American Medical Association, JAMA Cardiology, Medscape, JACC (Journal of the American College of Cardiology), NeurologyLive, Urologic Clinics of North America, Parallax by Ankur Kalra

Get in touch with Akshay

Contact Akshay, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Finerenone and Blood Pressure in Heart Failure With Mildly Reduced or Preserved Ejection Fraction : The FINEARTS-HF Randomized Clinical Trial

|
By John W. Ostrominski, Brian Claggett, Ian J. Kulac, Akshay Desai, Pardeep S. Jhund, Alasdair Henderson, Carolyn S.P. Lam, Michele Senni, Sanjiv Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Meike Brinker, Patrick Schloemer, John McMurray, Scott Solomon Verified, Muthiah Vaduganathan, Lucas Hofmeister
| JAMA Cardiology
Finerenone and Blood Pressure in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial Hypertension is observed in approximately 90% of people with heart failure (HF) with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF),1-3 and optimal blood pressure (BP) management is a guideline-directed priority of HF management.4,5 All guideline-recommended pharmacotherapies for HFpEF treatment have been shown to lower BP, and their...
Open in Who Shared Issue with article?

Systemic Treatments of Castration-Resistant Prostate Cancer

|
By Michelle Fleyshman, New Brunswick, Akshay Desai
| Urologic Clinics of North America Verified
Keywords Prostate Cancer Metastatic Systemic therapy Castration-resistant Get full text access Log in, subscribe or purchase for full access. References 1. Siegel, R.L. ∙ Kratzer, T.B. ∙ Giaquinto, A.N. ... Cancer statistics, 2025 CA A Cancer J Clinicians. 2025; 75(1):10-45 2. Einstein, D.J. ∙ Regan, M.M. ∙ Stevens, J.S. ... Metastasis-free survival versus treatment-free survival in biochemically recurrent prostate cancer: the EMBARK trial J Clin Oncol. 2024; 42(24):2849-2852 3.
Open in Who Shared Issue with article?

Evolving Therapies for HFpEF Management

|
By Akshay Desai
| Medscape Verified
Treatment strategies for heart failure have traditionally focused on patients with reduced ejection fraction. In this ReCAP, promising evidence for an integrated approach for management of heart failure with preserved ejection fraction (HFpEF) is reviewed by Dr Akshay S. Desai of Harvard Medical School, Boston, Massachusetts.
Open in Who Shared Issue with article?
See all 22 licensed articles (28 Total)